Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Manzano

Showing results (61-70 of 179) with videos related to

Pageof 18
Sort By:
Revista Espanola De Enfermedades Digestivas|August 21, 2002
Lung changes and cytokine levels in a model of experimental acute pancreatitisG Mozo, M L del Olmo, A Caro-Patón, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 1999
Immunological changes in peripheral blood mononuclear cells of patients with metastatic renal cell carcinoma after low doses of subcutaneous immunotherapy with IFN-alpha-2b and IL-2L Moltó, J Carballido, L Manzano, et al.
Revista Clinica Espanola|November 6, 2009
[Cardiac myxoma: an analysis of 30 patients]C García Zubiri, M Yebra Yebra, C Salas Antón, et al.
Hepato-Gastroenterology|December 2, 2000
Twelve-month interferon-alpha therapy induces a similar sustained response in anti-HBe-positive and HBeAg-positive chronic hepatitis B patientsI Fernández, G Castellano, M L Manzano, et al.
Gut|February 1, 1992
Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2L Manzano, M Alvarez-Mon, L Abreu, et al.
Hepatology (Baltimore, Md.)|September 1, 1992
Increased spontaneous and lymphokine-conditioned IgA and IgG synthesis by B cells from alcoholic cirrhotic patientsJ A Girón, M Alvarez-Mon, J L Menéndez-Caro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary siteC Balaña, J-L Manzano, I Moreno, et al.
British Journal of Cancer|December 1, 1994
Intracavitary prophylactic treatment with interferon alpha 2b of patients with superficial bladder cancer is associated with a systemic T-cell activationL Molto, M Alvarez-Mon, J Carballido, et al.
Trends in Pharmacological Sciences|October 2, 2023
Unravelling the signaling power of pollutantsAna L Manzano-Covarrubias, Hong Yan, Minh D A Luu, et al.
European Journal of Internal Medicine|June 15, 2019
External validation of the CACE-HF risk score for mortality in patients with heart failureR Quirós-López, L Manzano-Espinosa, A Bilbao, et al.
Pageof 18

Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
Revista Espanola De Enfermedades Digestivas|August 21, 2002
Lung changes and cytokine levels in a model of experimental acute pancreatitisG Mozo, M L del Olmo, A Caro-Patón, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 1999
Immunological changes in peripheral blood mononuclear cells of patients with metastatic renal cell carcinoma after low doses of subcutaneous immunotherapy with IFN-alpha-2b and IL-2L Moltó, J Carballido, L Manzano, et al.
Revista Clinica Espanola|November 6, 2009
[Cardiac myxoma: an analysis of 30 patients]C García Zubiri, M Yebra Yebra, C Salas Antón, et al.
Hepato-Gastroenterology|December 2, 2000
Twelve-month interferon-alpha therapy induces a similar sustained response in anti-HBe-positive and HBeAg-positive chronic hepatitis B patientsI Fernández, G Castellano, M L Manzano, et al.
Gut|February 1, 1992
Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2L Manzano, M Alvarez-Mon, L Abreu, et al.
Hepatology (Baltimore, Md.)|September 1, 1992
Increased spontaneous and lymphokine-conditioned IgA and IgG synthesis by B cells from alcoholic cirrhotic patientsJ A Girón, M Alvarez-Mon, J L Menéndez-Caro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary siteC Balaña, J-L Manzano, I Moreno, et al.
British Journal of Cancer|December 1, 1994
Intracavitary prophylactic treatment with interferon alpha 2b of patients with superficial bladder cancer is associated with a systemic T-cell activationL Molto, M Alvarez-Mon, J Carballido, et al.
Trends in Pharmacological Sciences|October 2, 2023
Unravelling the signaling power of pollutantsAna L Manzano-Covarrubias, Hong Yan, Minh D A Luu, et al.
European Journal of Internal Medicine|June 15, 2019
External validation of the CACE-HF risk score for mortality in patients with heart failureR Quirós-López, L Manzano-Espinosa, A Bilbao, et al.
Pageof 18